154 related articles for article (PubMed ID: 27863301)
1. Antioxidant and anticancer effects and bioavailability studies of the flavonoid baicalin and its oxidovanadium(IV) complex.
Martínez Medina JJ; Naso LG; Pérez AL; Rizzi A; Ferrer EG; Williams PAM
J Inorg Biochem; 2017 Jan; 166():150-161. PubMed ID: 27863301
[TBL] [Abstract][Full Text] [Related]
2. Antioxidant, anticancer activities and mechanistic studies of the flavone glycoside diosmin and its oxidovanadium(IV) complex. Interactions with bovine serum albumin.
Naso L; Martínez VR; Lezama L; Salado C; Valcarcel M; Ferrer EG; Williams PAM
Bioorg Med Chem; 2016 Sep; 24(18):4108-4119. PubMed ID: 27374881
[TBL] [Abstract][Full Text] [Related]
3. Bovine serum albumin binding, antioxidant and anticancer properties of an oxidovanadium(IV) complex with luteolin.
Naso LG; Lezama L; Valcarcel M; Salado C; Villacé P; Kortazar D; Ferrer EG; Williams PA
J Inorg Biochem; 2016 Apr; 157():80-93. PubMed ID: 26828287
[TBL] [Abstract][Full Text] [Related]
4. Antimetastatic effects of VOflavonoid complexes on A549 cell line.
Naso LG; Martínez VR; Ferrer EG; Williams PAM
J Trace Elem Med Biol; 2021 Mar; 64():126690. PubMed ID: 33260045
[TBL] [Abstract][Full Text] [Related]
5. Behavior of the potential antitumor V(IV)O complexes formed by flavonoid ligands. 3. Antioxidant properties and radical production capability.
Sanna D; Ugone V; Fadda A; Micera G; Garribba E
J Inorg Biochem; 2016 Aug; 161():18-26. PubMed ID: 27184413
[TBL] [Abstract][Full Text] [Related]
6. Study on the cytotoxic, antimetastatic and albumin binding properties of the oxidovanadium(IV) chrysin complex. Structural elucidation by computational methodologies.
Naso LG; Martínez Medina JJ; Okulik NB; Ferrer EG; Williams PAM
Chem Biol Interact; 2022 Jan; 351():109750. PubMed ID: 34813780
[TBL] [Abstract][Full Text] [Related]
7. Promising antioxidant and anticancer (human breast cancer) oxidovanadium(IV) complex of chlorogenic acid. Synthesis, characterization and spectroscopic examination on the transport mechanism with bovine serum albumin.
Naso LG; Valcarcel M; Roura-Ferrer M; Kortazar D; Salado C; Lezama L; Rojo T; González-Baró AC; Williams PA; Ferrer EG
J Inorg Biochem; 2014 Jun; 135():86-99. PubMed ID: 24681549
[TBL] [Abstract][Full Text] [Related]
8. Biological evaluation of morin and its new oxovanadium(IV) complex as antioxidant and specific anti-cancer agents.
Naso LG; Lezama L; Rojo T; Etcheverry SB; Valcarcel M; Roura M; Salado C; Ferrer EG; Williams PA
Chem Biol Interact; 2013 Nov; 206(2):289-301. PubMed ID: 24125835
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and antioxidant activities of transition metal complexes based 3-hydroxysalicylaldehyde-S-methylthiosemicarbazone.
Bal-Demirci T; Şahin M; Kondakçı E; Özyürek M; Ülküseven B; Apak R
Spectrochim Acta A Mol Biomol Spectrosc; 2015 Mar; 138():866-72. PubMed ID: 25467658
[TBL] [Abstract][Full Text] [Related]
10. Insights into the mechanisms underlying the antitumor activity of an oxidovanadium(IV) compound with the antioxidant naringenin. Albumin binding studies.
Islas MS; Naso LG; Lezama L; Valcarcel M; Salado C; Roura-Ferrer M; Ferrer EG; Williams PA
J Inorg Biochem; 2015 Aug; 149():12-24. PubMed ID: 25957189
[TBL] [Abstract][Full Text] [Related]
11. Curcumin "Drug" Stabilized in Oxidovanadium(IV)-BODIPY Conjugates for Mitochondria-Targeted Photocytotoxicity.
Bhattacharyya U; Kumar B; Garai A; Bhattacharyya A; Kumar A; Banerjee S; Kondaiah P; Chakravarty AR
Inorg Chem; 2017 Oct; 56(20):12457-12468. PubMed ID: 28972748
[TBL] [Abstract][Full Text] [Related]
12. Role of oxidative stress in the antitumoral action of a new vanadyl(IV) complex with the flavonoid chrysin in two osteoblast cell lines: relationship with the radical scavenger activity.
Naso L; Ferrer EG; Lezama L; Rojo T; Etcheverry SB; Williams P
J Biol Inorg Chem; 2010 Aug; 15(6):889-902. PubMed ID: 20364393
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of cellular uptake, cytotoxicity and cellular ultrastructural effects of heteroleptic oxidovanadium(IV) complexes of salicylaldimines and polypyridyl ligands.
Scalese G; Correia I; Benítez J; Rostán S; Marques F; Mendes F; Matos AP; Costa Pessoa J; Gambino D
J Inorg Biochem; 2017 Jan; 166():162-172. PubMed ID: 27865131
[TBL] [Abstract][Full Text] [Related]
14. Antiproliferative and apoptosis-inducing activity of an oxidovanadium(IV) complex with the flavonoid silibinin against osteosarcoma cells.
Leon IE; Porro V; Di Virgilio AL; Naso LG; Williams PA; Bollati-Fogolín M; Etcheverry SB
J Biol Inorg Chem; 2014 Jan; 19(1):59-74. PubMed ID: 24233155
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, crystal structures and spectroscopy of meclofenamic acid and its metal complexes with manganese(II), copper(II), zinc(II) and cadmium(II). Antiproliferative and superoxide dismutase activity.
Kovala-Demertzi D; Staninska M; Garcia-Santos I; Castineiras A; Demertzis MA
J Inorg Biochem; 2011 Sep; 105(9):1187-95. PubMed ID: 21718655
[TBL] [Abstract][Full Text] [Related]
16. In vitro apoptosis-induction, antiproliferative and BSA binding studies of a oxidovanadium(V) complex.
Kongot M; Dohare N; Reddy DS; Pereira N; Patel R; Subramanian M; Kumar A
J Trace Elem Med Biol; 2019 Jan; 51():176-190. PubMed ID: 30466929
[TBL] [Abstract][Full Text] [Related]
17. Antioxidant, DNA cleavage, and cellular effects of silibinin and a new oxovanadium(IV)/silibinin complex.
Naso LG; Ferrer EG; Butenko N; Cavaco I; Lezama L; Rojo T; Etcheverry SB; Williams PA
J Biol Inorg Chem; 2011 Apr; 16(4):653-68. PubMed ID: 21399988
[TBL] [Abstract][Full Text] [Related]
18. Ternary copper(II) complex of 5-hydroxytryptophan and 1,10-phenanthroline with several pharmacological properties and an adequate safety profile.
Naso LG; Martínez Medina JJ; D'Alessandro F; Rey M; Rizzi A; Piro OE; Echeverría GA; Ferrer EG; Williams PAM
J Inorg Biochem; 2020 Mar; 204():110933. PubMed ID: 31825796
[TBL] [Abstract][Full Text] [Related]
19. Oxidovanadium(IV) Complex Disrupts Mitochondrial Membrane Potential and Induces Apoptosis in Pancreatic Cancer Cells.
Kowalski S; Tesmar A; Sikorski A; Inkielewicz-Stępniak I
Anticancer Agents Med Chem; 2021; 21(1):71-83. PubMed ID: 32579508
[TBL] [Abstract][Full Text] [Related]
20. EPR and photophysical characterization of six bioactive oxidovanadium(IV) complexes in the conditions of in vitro cell tests.
Lovisari M; Volpi G; Marabello D; Cadamuro S; Deagostino A; Diana E; Barge A; Gallicchio M; Boscaro V; Ghibaudi E
J Inorg Biochem; 2017 May; 170():55-62. PubMed ID: 28222390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
